AcelRx Pharmaceuticals Inc
As of September 18 - 3:55PM EDT
Currency in USD - NASDAQ
TICKERA ticker symbol, or a stock symbol, is a unique identifier assigned to a particular stock on a parti...
COMPANY SIZEA company's size is based on it's Market Capitalization and ranges between Small, Medium and Large:
CEOA Chief Executive Officer is the highest-ranking executive in a company, and their primary responsib...
Vincent J. Angotti
Medical Appliances & Equipment
351 Galveston Drive, Redwood City, Ca 94063
Toggle short/long description
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. Its product candidates is comprised of DSUVIA, and ZALVISO, which both contains sufentanil as a therapeutic ingredient. The company was founded by Thomas A. Schreck and Pamela P. Palmer on July 13, 2005 and is headquartered in Redwood City, CA.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA, a 30 mcg sufentanil sublingual tablet, which is in Phase III clinical trial for the treatment of moderate-to-severe acute pain. The company's late-stage investigational product candidate is Zalviso, a pre-programmed and patient-controlled analgesia device that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain. Zalviso is approved in the European Union, Switzerland, Liechtenstein, Iceland, Norway and Australia, or the Territory; and is under development stage in the United States. The company was formerly known as SuRx Pharmaceuticals, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Redwood City, California.
Dividend YieldDividend Yield is the percentage amount relative to its share price a company is paying out in divid...
Enterprise Value to EBITDAEnterprise Value to EBITDA - Earnings before interest, taxes, depreciation and amortization.
Price to BookPrice to Book compares a company's book value to its current market price. Book value shows the por...
Price to EarningsPrice to Earnings, or the P/E ratio, is one of the most common valuation ratios. It shows how much ...
Price to SalesPrice to Sales indicates the value placed on each dollar of a company's sales by comparing their sal...
6 Month MomentumMomentum is a measure of how fats a stock price has increased. It is calculated by comparing the pri...